YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect
about
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect
description
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
YLT-11, a novel PLK4 inhibitor ...... duplication and mitotic defect
@en
YLT-11, a novel PLK4 inhibitor ...... duplication and mitotic defect
@nl
type
label
YLT-11, a novel PLK4 inhibitor ...... duplication and mitotic defect
@en
YLT-11, a novel PLK4 inhibitor ...... duplication and mitotic defect
@nl
prefLabel
YLT-11, a novel PLK4 inhibitor ...... duplication and mitotic defect
@en
YLT-11, a novel PLK4 inhibitor ...... duplication and mitotic defect
@nl
P2093
P2860
P1476
YLT-11, a novel PLK4 inhibitor ...... duplication and mitotic defect
@en
P2093
Cuiting Peng
Luoting Yu
Ningyu Wang
Tiantao Gao
Tinghong Ye
Xuejiao Song
P2860
P356
10.1038/S41419-018-1071-2
P407
P577
2018-10-18T00:00:00Z